Global Cardiac Rhythm Management Devices Market Grows Steadily at a CAGR of 5.79%

Introduction

Cardiac rhythm management (CRM) devices are medical devices used to monitor, regulate, and manage abnormal heart rhythms, also known as arrhythmias. These devices are primarily designed to deliver electrical impulses to the heart to restore normal rhythm or to prevent dangerous arrhythmias. Common CRM devices include pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and subcutaneous ICDs. These devices help manage conditions such as bradycardia, atrial fibrillation, and heart failure by ensuring the heart maintains an appropriate rhythm and rate.

Technological integration in CRM devices drives the global market

Technological innovations are reshaping cardiac rhythm management (CRM) devices, prioritizing enhanced patient outcomes and improved device performance. Cutting-edge developments, such as leadless pacemakers, implantable cardioverter defibrillators (ICDs), and remote monitoring systems, are revolutionizing cardiac care.

A prime example is the Medtronic Micra AV2, a compact, leadless pacemaker that enhances patient comfort, reduces the risk of infections, and simplifies the implantation process compared to conventional pacemakers. These advancements highlight a shift towards patient-focused technologies, making CRM devices more effective, accessible, and adaptable to various medical needs.

Rising adoption of wearable cardioverter defibrillators creates tremendous opportunities

The use of wearable cardioverter defibrillators (WCDs) is gaining significant momentum as they offer a non-invasive and efficient option for patients temporarily at risk of sudden cardiac arrest. These devices continuously monitor heart rhythms and deliver life-saving shocks when severe arrhythmias occur, minimizing the need for immediate invasive procedures.

A notable example is LifeVest by ZOLL Medical Corporation, a widely adopted WCD known for its reliability and user-friendly design, providing 24/7 cardiac protection. The rising demand for non-invasive cardiac technologies, combined with broader clinical applications for WCDs, is driving their adoption. This trend is unlocking considerable growth potential in the market by addressing the need for effective and patient-centric solutions.

North America holds a commanding position in the cardiac rhythm management (CRM) devices market, capturing the largest revenue share. This dominance is driven by several key factors, including the high prevalence of cardiovascular diseases, a well-established healthcare infrastructure, and the widespread adoption of cutting-edge technologies like leadless pacemakers and AI-powered diagnostic tools.

Moreover, supportive reimbursement policies and substantial investments in research and development (R&D) further bolster the market's growth in the region. The strong presence of major players, coupled with a favorable regulatory environment, has also positioned North America as a leader in CRM technology innovation.

Key Highlights

• The global cardiac rhythm management devices market size was valued at USD 17,170.20 million in 2024 and is projected to grow from USD 18,441.67 million in 2025 to reach USD 28,933.88 million by 2033, exhibiting a CAGR of 5.79% during the forecast period (2025-2033).
• By product, the global market is segmented into pacemakers, defibrillators, and cardiac resynchronization therapy (CRT). The defibrillators segment accounted for the major market share.
• By end-user, the global market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment is anticipated to exhibit the fastest CAGR.
• North America is the most significant global market shareholder.

Competitive Players

The key players in the global market include Physio-Control, Inc., Medtronic, plc, ABBOTT, Boston Scientific Corporation, Schiller, Koninklijke Philips N.V., Biotronik, Progetti Srl, Zoll Medical Corporation, LivaNova Plc, Defibtech LLC, CU Medical Germany GmbH, Asahi Kasei Corporation, Lepu Medical Technology (Beijing) Co., Ltd., and others.

Recent Developments

• In January 2024 - Medtronic, a global leader in medical technology, partnered with Cardiac Design Labs (CDL) to introduce Padma Rhythms®, an advanced external loop recorder (ELR) patch for comprehensive, long-term heart monitoring and diagnosis in India. This collaboration aims to enhance early disease identification and management for patients, enabling them to monitor their heart health from their homes.

Segmentation

1. By Product
   1. Pacemakers
      1. Implantable
      2. External
   2. Defibrillators
      1. Implantable Cardioverter Defibrillators (ICD)
         1. S-ICD
         2. T-ICD
      2. External Defibrillator
         1. Manual External Defibrillator
         2. Automatic External Defibrillator
         3. Wearable Cardioverter Defibrillator
   3. Cardiac Resynchronization Therapy (CRT)CRT-Defibrillator
   4. CRT-Pacemakers
2. By End-User
   1. Hospitals
   2. Ambulatory Surgical Centers
   3. Others